Free Submission Public Relations &
Deutsch English


Pharmaceutical Innovators Share eClinical Research Best Practices at 10th Annual PRO & eCOA Congress, Europe’s Only Dedicated eClinical Outcome Assessment Educational Event

Print article Print article
© Business Wire 2014
2014-04-03 09:01:01 -

The most progressive minds in Europe’s pharmaceutical research community will convene at the PRO & eCOA Congress, Europe : .. 3-5 June in Barcelona, Spain. Registration : .. is now open for this educational event centered on the science, technologies and regulatory requirements of PROs and eCOAs.

The Congress is hosted by PHT Corporation : .. , the leading provider of technologies used to collect patient-driven eData : .. for clinical research. PHT provides sponsors and CROs the flexibility to deploy clinical outcome assessments on the web, smartphones and tablets including patients’ own devices.

The Congress is attended by pharmaceutical and biotechnology professionals in clinical operations, outsourcing, data management, eClinical technologies,

regulatory affairs, and health outcomes as well as PRO and eCOA thought leaders, regulators and sites. Attendees participate in educational sessions and share experiences with peers during networking activities.

Register here: : ..

Sheila Rocchio, MBA, PHT Vice President of Marketing and Product Management, said, “The Congress is a world-class event where eClinical visionaries make serious and meaningful advances in adopting eCOA technologies to enable patient-centric clinical research. There is no other meeting in Europe like the eCOA Congress – 94% of last years’ attendees said they would strongly recommend the meeting to a colleague.” Learn more about the PRO & eCOA Congress in one minute: : ..

Speakers include representatives from Celgene, Astellas and other leading pharmaceutical companies, research sites and industry organizations as well as PHT executive leadership. Examples of the type of content attendees receive are reflected in these recent publications that resulted from previous Congress sessions.

- Patients Prefer electronic COA (eCOA) Over Paper PRO : ..
- How to Implement an ePRO Strategy: A Best Practices Guide : ..
- Using ePRO for the First Time : .. ; Lessons Learned from a Trial Manager’s Perspective
- New FDA Roadmap App : .. developed by PHT to Easily Navigate the FDA Roadmap to Patient-Focused Outcome Measurement in Clinical Trials

The agenda : .. combines presentations, case studies, workshops and roundtable discussions that focus on the latest PRO and eCOA innovations, case studies and best practices. Learn more here: : .. .

Meet PHT at the Outsourcing in Clinical Trials Europe : .. , 21-22 May to be entered to win one free PRO & eCOA Congress registration and hotel accommodation in Barcelona.
PHT invites all Congress alumni to join the exclusive PRO & eCOA Congress LinkedIn Community : .. to exchange information, ideas and experiences throughout the year.

About PHT Corporation

PHT Corporation is the eClinical innovator leading the adoption of patient-driven mobile apps for better clinical research. The PHT electronic clinical outcome assessment (eCOA) system collects and reports secure real-time patient data from the latest mobile devices.
PHT scientific, regulatory and technological expertise combined with quality outcomes data enable clients to make research decisions with confidence. Sponsors and CROs have leveraged the PHT Patient Suite in 650+ trials resulting in 16+ regulatory approvals. Visit : .. for more information on PHT. Follow PHT on LinkedIn : .. , Twitter : .. , Google+ : .. and YouTube : .. .

" title="\"/>" target="_blank" rel="nofollow"> ..

Brenda Nashawaty CommunicationsBrenda Nashawaty, 617-688-3253 :

Hossam Abdel-Kader
Phone: +43 1 9582319

Disclaimer: (c) 2014 Business Wire. All of the news releases contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Business Wire's members, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
Latest News
Read the Latest News


Terms & Conditions | Privacy | About us | Contact